If a company cannot provide verifiable, independent testing for the specific batch you are buying, you should not use the product
Diabetes mellitus, a significant risk factor for neuropathy, leads to high blood glucose levels that harm the small blood vessels supplying nerves, subsequently compromising nerve functionality
With time and practice, the process often becomes easier
BPC-157 is still a research-stage compound with limited human clinical evidence, so the only responsible way to evaluate a product like this is to separate (1) what the company discloses and can document (testing, formulation, policies) from (2) what preclinical research suggests in animals or lab settings, and (3) what remains unproven in humans
What we have on BPC-157, the headliner of the July hearing, is animal and cell studies, as well as testimonials